Tripla negatív emlőrák: vizsgálatok itt: Hollandia
13 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 12.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
- Where
- Amersfoort, Arnhem, Deventer, Groningen, Rotterdam, Sittard Geleen, Tilburg
- Életkor
- 18 év and over
- People
- 1000 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06841354 · EU 2024-516834-36-00 - 3. fázisTaking peopleROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
- Where
- Amsterdam, Hoofddorp, Maastricht, Rotterdam, 's-Gravenhage
- Életkor
- 18 év and over
- People
- 558 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT07173751 · EU 2025-521884-12-00 - 2. fázisTaking peoplePan-tumor neoadjuvant basket study of immune check-point inhibition and novel IO combinations (NEOASIS)
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 153
- Run by
- Netherlands Cancer Institute
See details and how to joinNCT06279130 · EU 2023-505756-21-00 - No phaseTaking peopleTAO-Towards Optimal (Neo)Adjuvant Systemic Therapy of Stage III Triple-negative Breast Cancer
- Where
- Amsterdam, Breda, Deventer, Enschede, Groningen, Maastricht, Nijmegen, Rotterdam
- Életkor
- 18 év and over
- People
- 100
- Run by
- The Netherlands Cancer Institute
See details and how to joinNCT06931769 - 1/2. fázisTaking peopleA Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
- Where
- Amsterdam, Leiden
- Életkor
- 18 év and over
- People
- 416 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06618287 - 1. fázisTaking peoplePhase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
- Where
- Nijmegen, Utrecht
- Életkor
- 18 év to 100 év
- People
- 162 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06562192 - 1. fázisTaking peopleA Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 714 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT05208762 · EU 2023-506604-18-00 - No phaseTaking peopleThe TASTY-steering Study
- Where
- Amsterdam, Arnhem, Dirksland, Ede, Groningen, Nijmegen, Rotterdam, Scheemda, Veldhoven, Zwolle
- Életkor
- 18 év to 70 év
- People
- 201
- Run by
- University Medical Center Groningen
See details and how to joinNCT07258563 - 3. fázisNot yet taking people in HollandiaPembrolizumab Adjuvant in Patients With Early-stage Triple Negative Breast Cancer With Residual Disease After Neoadjuvant Pembrolizumab Plus Chemotherapy
- Where
- Alkmaar, Almelo, Almere, Amersfoort, Amstelveen, Amsterdam, Apeldoorn, Arnhem, Assen, Beverwijk, Breda, Capelle aan den IJssel, Delft, Deventer, Dirksland, Doetinchem, Dordrecht, Drachten, Ede Gld, Eindhoven, Emmen, Enschede, Geldrop, Goes, Gorinchem, Gouda, Groningen, Harderwijk, Heerlen, Hilversum, Hoofddorp, Hoorn Nh, Leeuwarden, Leiderdorp, Leidschendam, Maastricht, Nieuwegein, Nijmegen, Roermond, Roosendaal, Rotterdam, Scheemda, Schiedam, 's-Gravenhage, 'S-Hertogenbosch, Sneek, Terneuzen, Tilburg, Uden, Utrecht, Venlo, Weert, Winterswijk, Zaandam, Zwolle
- Életkor
- 18 év and over
- People
- 1000
- Run by
- The Netherlands Cancer Institute
See details and how to joinNCT07486687 · EU 2025-524229-41-00 - 1/2. fázisTaking peoplePhase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI
- Where
- Maastricht, Rotterdam
- Életkor
- 18 év and over
- People
- 126 worldwide
- Run by
- Maastricht University Medical Center
See details and how to joinNCT04954599 - No phaseTaking peopleOPTImaL:Optimisation of Treatment for Patients With Low Stage Triple-negative Breast Cancer With High Stromal Tumor-infiltrating Lymphocytes
- Where
- Alkmaar, Almere Stad, Amersfoort, Amsterdam, Arnhem, Breda, Deventer, Ede, Eindhoven, Enschede, Harderwijk, Hengelo, Hilversum, Hoofddorp, Hoorn, Leeuwarden, Leiden, Maastricht, Nieuwegein, Nijmegen, Rotterdam, Schiedam, Sittard-Geleen, The Hague, Venlo, Zwolle
- Életkor
- 18 év and over
- People
- 490
- Run by
- The Netherlands Cancer Institute
See details and how to joinNCT06476119 - 2. fázisTaking peopleNOvel Immunotherapy Strategies for Advanced Triple Negative Breast Cancer (TNBC) Patients: TONIC-3 Trial
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 60
- Run by
- The Netherlands Cancer Institute
See details and how to joinNCT06342037 - 2. fázisTaking peopleImmune Induction Strategies to Improve Response to Immune Checkpoint Blockade in Triple Negative Breast Cancer (TNBC) Patients
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 52
- Run by
- The Netherlands Cancer Institute
See details and how to joinNCT04159818 · EU 2024-513217-12-00